{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:31:34Z","timestamp":1791415894907,"version":"4.3.3"},"reference-count":78,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.idc.2007.12.011","type":"journal-article","created":{"date-parts":[[2008,4,30]],"date-time":"2008-04-30T16:33:13Z","timestamp":1209573193000},"page":"341-360","source":"Crossref","is-referenced-by-count":173,"title":["Chronic Lyme Disease: A Review"],"prefix":"10.1016","volume":"22","author":[{"given":"Adriana","family":"Marques","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.idc.2007.12.011_bib1","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1056\/NEJMra072023","article-title":"A critical appraisal of chronic Lyme disease","volume":"357","author":"Feder","year":"2007","journal-title":"N Engl J Med"},{"issue":"5407","key":"10.1016\/j.idc.2007.12.011_bib2","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1126\/science.283.5407.1431","article-title":"Lyme disease. Patients scarce in test of long-term therapy","volume":"283","author":"Marshall","year":"1999","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.idc.2007.12.011_bib3","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1212\/01.WNL.0000071227.23769.9E","article-title":"Study and treatment of post Lyme disease (STOP-LD): a randomized double-masked clinical trial","volume":"60","author":"Krupp","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.idc.2007.12.011_bib4","article-title":"A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy","author":"Fallon","year":"2007","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.idc.2007.12.011_bib5","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0002-9343(90)90520-N","article-title":"Summary of the first 100 patients seen at a Lyme disease referral center","volume":"88","author":"Sigal","year":"1990","journal-title":"Am J Med"},{"issue":"14","key":"10.1016\/j.idc.2007.12.011_bib6","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1001\/jama.1993.03500140064037","article-title":"The overdiagnosis of Lyme disease","volume":"269","author":"Steere","year":"1993","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.idc.2007.12.011_bib7","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1177\/000992289403301105","article-title":"The overdiagnosis of Lyme disease in children residing in an endemic area","volume":"33","author":"Rose","year":"1994","journal-title":"Clin Pediatr"},{"issue":"1","key":"10.1016\/j.idc.2007.12.011_bib8","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/jama.1995.03530010080038","article-title":"Pitfalls in the diagnosis and treatment of Lyme disease in children","volume":"274","author":"Feder","year":"1995","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.idc.2007.12.011_bib9","doi-asserted-by":"crossref","first-page":"354","DOI":"10.7326\/0003-4819-128-5-199803010-00003","article-title":"The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study","volume":"128","author":"Reid","year":"1998","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.idc.2007.12.011_bib10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00006454-200201000-00003","article-title":"Overdiagnosis and overtreatment of Lyme disease in children","volume":"21","author":"Qureshi","year":"2002","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.idc.2007.12.011_bib11","doi-asserted-by":"crossref","first-page":"421","DOI":"10.7326\/0003-4819-136-6-200203190-00005","article-title":"Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans","volume":"136","author":"Smith","year":"2002","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.idc.2007.12.011_bib12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-9343(03)00308-5","article-title":"Long-term follow-up of patients with culture-confirmed Lyme disease","volume":"115","author":"Nowakowski","year":"2003","journal-title":"Am J Med"},{"issue":"9","key":"10.1016\/j.idc.2007.12.011_bib13","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-138-9-200305060-00005","article-title":"Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial","volume":"138","author":"Wormser","year":"2003","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.idc.2007.12.011_bib14","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"8596","key":"10.1016\/j.idc.2007.12.011_bib15","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(88)92011-9","article-title":"Treatment of late Lyme borreliosis\u2014randomised comparison of ceftriaxone and penicillin","volume":"1","author":"Dattwyler","year":"1988","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.idc.2007.12.011_bib16","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/infdis\/163.2.311","article-title":"Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis","volume":"163","author":"Pfister","year":"1991","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2007.12.011_bib17","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/art.1780370616","article-title":"Treatment of Lyme arthritis","volume":"37","author":"Steere","year":"1994","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.idc.2007.12.011_bib18","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1086\/318082","article-title":"Evaluation of study patients with Lyme disease, 10- to 20-year follow-up","volume":"183","author":"Kalish","year":"2001","journal-title":"J\u00a0Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2007.12.011_bib19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1034\/j.1600-0404.2002.01336.x","article-title":"Peripheral neuropathy in acrodermatitis chronica atrophicans\u2014effect of treatment","volume":"106","author":"Kindstrand","year":"2002","journal-title":"Acta Neurol Scand"},{"issue":"6","key":"10.1016\/j.idc.2007.12.011_bib20","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/00365540110080421","article-title":"5-y follow-up study of patients with neuroborreliosis","volume":"34","author":"Berglund","year":"2002","journal-title":"Scand J Infect Dis"},{"issue":"11\u201312","key":"10.1016\/j.idc.2007.12.011_bib21","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00508-005-0361-8","article-title":"A comparison of two treatment regimens of ceftriaxone in late Lyme disease","volume":"117","author":"Dattwyler","year":"2005","journal-title":"Wien Klin Wochenschr"},{"issue":"6\u20137","key":"10.1016\/j.idc.2007.12.011_bib22","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/00365540510027228","article-title":"Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis","volume":"37","author":"Borg","year":"2005","journal-title":"Scand J Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2007.12.011_bib23","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s10096-007-0340-2","article-title":"Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study","volume":"26","author":"Oksi","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2007.12.011_bib24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nri1267","article-title":"Elucidation of Lyme arthritis","volume":"4","author":"Steere","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.idc.2007.12.011_bib25","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1749-6632.1988.tb31867.x","article-title":"Antibiotic therapy of early European Lyme borreliosis and acrodermatitis chronica atrophicans","volume":"539","author":"Weber","year":"1988","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1016\/j.idc.2007.12.011_bib26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF01710737","article-title":"Azithromycin versus doxycycline for treatment of erythema migrans: clinical and microbiological findings","volume":"21","author":"Strle","year":"1993","journal-title":"Infection"},{"issue":"5","key":"10.1016\/j.idc.2007.12.011_bib27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1056\/NEJM199707313370501","article-title":"Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease","volume":"337","author":"Dattwyler","year":"1997","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.idc.2007.12.011_bib28","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1080\/00365540600810000","article-title":"Symptoms of post-Lyme syndrome in long-term outcome of patients with neuroborreliosis","volume":"38","author":"Picha","year":"2006","journal-title":"Scand J Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2007.12.011_bib29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.7326\/0003-4819-99-1-22","article-title":"Treatment of the early manifestations of Lyme disease","volume":"99","author":"Steere","year":"1983","journal-title":"Ann Intern Med"},{"issue":"8728","key":"10.1016\/j.idc.2007.12.011_bib30","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/0140-6736(90)93103-V","article-title":"Amoxicillin plus probenecid versus doxycycline for treatment of erythema migrans borreliosis","volume":"336","author":"Dattwyler","year":"1990","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.idc.2007.12.011_bib31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF01641422","article-title":"A randomized trial of ceftriaxone versus oral penicillin for the treatment of early European Lyme borreliosis","volume":"18","author":"Weber","year":"1990","journal-title":"Infection"},{"issue":"8","key":"10.1016\/j.idc.2007.12.011_bib32","doi-asserted-by":"crossref","first-page":"560","DOI":"10.7326\/0003-4819-121-8-199410150-00002","article-title":"The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study","volume":"121","author":"Shadick","year":"1994","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.idc.2007.12.011_bib33","first-page":"454","article-title":"Lyme disease: an infectious and postinfectious syndrome","volume":"21","author":"Asch","year":"1994","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.idc.2007.12.011_bib34","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0022-3476(05)83541-3","article-title":"Long-term outcome of Lyme disease in children given early treatment","volume":"122","author":"Salazar","year":"1993","journal-title":"J Pediatr"},{"issue":"17","key":"10.1016\/j.idc.2007.12.011_bib35","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1056\/NEJM199610243351703","article-title":"Lyme disease in children in southeastern Connecticut. Pediatric Lyme Disease Study Group","volume":"335","author":"Gerber","year":"1996","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.idc.2007.12.011_bib36","first-page":"2249","article-title":"Outcomes of children treated for Lyme disease","volume":"25","author":"Wang","year":"1998","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.idc.2007.12.011_bib37","first-page":"1190","article-title":"Cognitive effects of Lyme disease in children: a 4-year follow-up study","volume":"26","author":"Adams","year":"1999","journal-title":"J\u00a0Rheumatol"},{"issue":"22\u201323","key":"10.1016\/j.idc.2007.12.011_bib38","first-page":"916","article-title":"Comparison of cefuroxime axetil and phenoxymethyl penicillin for the treatment of children with solitary erythema migrans","volume":"111","author":"Arnez","year":"1999","journal-title":"Wien Klin Wochenschr"},{"issue":"5","key":"10.1016\/j.idc.2007.12.011_bib39","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/jama.283.5.609","article-title":"Long-term outcomes of persons with Lyme disease","volume":"283","author":"Seltzer","year":"2000","journal-title":"JAMA"},{"issue":"13\u201314","key":"10.1016\/j.idc.2007.12.011_bib40","first-page":"498","article-title":"Solitary erythema migrans in children: comparison of treatment with azithromycin and phenoxymethylpenicillin","volume":"114","author":"Arnez","year":"2002","journal-title":"Wien Klin Wochenschr"},{"issue":"6","key":"10.1016\/j.idc.2007.12.011_bib41","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1542\/peds.109.6.1173","article-title":"Comparative study of cefuroxime axetil versus amoxicillin in children with early Lyme disease","volume":"109","author":"Eppes","year":"2002","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.idc.2007.12.011_bib42","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1097\/00006454-200212000-00011","article-title":"Successful treatment of neuroborreliosis with ten-day regimens","volume":"21","author":"Thorstrand","year":"2002","journal-title":"Pediatr Infect Dis J"},{"issue":"7568","key":"10.1016\/j.idc.2007.12.011_bib43","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/bmj.38933.585764.AE","article-title":"Postinfective and chronic fatigue syndromes precipitated by viral and nonviral pathogens: prospective cohort study","volume":"333","author":"Hickie","year":"2006","journal-title":"BMJ"},{"issue":"1\u20132","key":"10.1016\/j.idc.2007.12.011_bib44","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/s0304-3959(02)00372-x","article-title":"Musculoskeletal pain in the Netherlands: prevalences, consequences, and risk groups, the DMC(3)-study","volume":"102","author":"Picavet","year":"2003","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.idc.2007.12.011_bib45","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/ije\/dyi265","article-title":"The epidemiology of chronic syndromes that are frequently unexplained: do they have common associated factors?","volume":"35","author":"Aggarwal","year":"2006","journal-title":"Int J Epidemiol"},{"issue":"3","key":"10.1016\/j.idc.2007.12.011_bib46","first-page":"274","article-title":"Epidemiology of insomnia: a longitudinal study in a UK population","volume":"30","author":"Morphy","year":"2007","journal-title":"Sleep"},{"issue":"535","key":"10.1016\/j.idc.2007.12.011_bib47","first-page":"109","article-title":"The frequency and characteristics of chronic widespread pain in general practice: a case\u2013control study","volume":"57","author":"Rohrbeck","year":"2007","journal-title":"Br J Gen Pract"},{"issue":"5","key":"10.1016\/j.idc.2007.12.011_bib48","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1086\/317465","article-title":"Coexposure to Borrelia burgdorferi and Babesia microti does not worsen the long-term outcome of Lyme disease","volume":"31","author":"Wang","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2007.12.011_bib49","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJM200107123450202","article-title":"Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease","volume":"345","author":"Klempner","year":"2001","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.idc.2007.12.011_bib50","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3201\/eid0804.010222","article-title":"Outcomes of treated human granulocytic ehrlichiosis cases","volume":"8","author":"Ramsey","year":"2002","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2007.12.011_bib51","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1086\/432733","article-title":"A case\u2013control study to examine HLA haplotype associations in patients with post-treatment chronic Lyme disease","volume":"192","author":"Klempner","year":"2005","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2007.12.011_bib52","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/0002-9343(92)90270-L","article-title":"Treatment of early Lyme disease","volume":"92","author":"Massarotti","year":"1992","journal-title":"Am J Med"},{"issue":"9","key":"10.1016\/j.idc.2007.12.011_bib53","doi-asserted-by":"crossref","first-page":"785","DOI":"10.7326\/0003-4819-124-9-199605010-00002","article-title":"Azithromycin compared with amoxicillin in the treatment of erythema migrans. A double-blind, randomized, controlled trial","volume":"124","author":"Luft","year":"1996","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.idc.2007.12.011_bib54","doi-asserted-by":"crossref","first-page":"273","DOI":"10.7326\/0003-4819-117-4-273","article-title":"Comparison of cefuroxime axetil and doxycycline in the treatment of early Lyme disease","volume":"117","author":"Nadelman","year":"1992","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.idc.2007.12.011_bib55","doi-asserted-by":"crossref","first-page":"919","DOI":"10.7326\/0003-4819-131-12-199912210-00003","article-title":"Musculoskeletal and neurologic outcomes in patients with previously treated Lyme disease","volume":"131","author":"Shadick","year":"1999","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.idc.2007.12.011_bib56","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1128\/CMR.18.3.484-509.2005","article-title":"Diagnosis of lyme borreliosis","volume":"18","author":"Aguero-Rosenfeld","year":"2005","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.idc.2007.12.011_bib57","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1574-695X.2006.00139.x","article-title":"Microbiological and serological diagnosis of Lyme borreliosis","volume":"49","author":"Wilske","year":"2007","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"6","key":"10.1016\/j.idc.2007.12.011_bib58","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/BF02770837","article-title":"A proposal for the reliable culture of Borrelia burgdorferi from patients with chronic Lyme disease, even from those previously aggressively treated","volume":"26","author":"Phillips","year":"1998","journal-title":"Infection"},{"issue":"11","key":"10.1016\/j.idc.2007.12.011_bib59","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1128\/JCM.38.11.4239-4241.2000","article-title":"Evaluation of a new culture medium for Borrelia burgdorferi","volume":"38","author":"Marques","year":"2000","journal-title":"J\u00a0Clin Microbiol"},{"issue":"7","key":"10.1016\/j.idc.2007.12.011_bib60","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1128\/JCM.39.7.2747.2001","article-title":"Culture Borrelia burgdorferi","volume":"39","author":"Tilton","year":"2001","journal-title":"J Clin Microbiol"},{"issue":"5","key":"10.1016\/j.idc.2007.12.011_bib61","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF01716077","article-title":"Borrelia burgdorferi DNA in the urine of treated patients with chronic Lyme disease symptoms. A PCR study of 97 cases","volume":"24","author":"Bayer","year":"1996","journal-title":"Infection"},{"key":"10.1016\/j.idc.2007.12.011_bib62","first-page":"615","article-title":"Pre-treatment and post-treatment assessment of the C(6) test in patients with persistent symptoms and a history of Lyme borreliosis","volume":"8","author":"Fleming","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2007.12.011_bib63","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1128\/CDLI.12.9.1036-1040.2005","article-title":"Detection of immune complexes is not independent of detection of antibodies in Lyme disease patients and does not confirm active infection with Borrelia burgdorferi","volume":"12","author":"Marques","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"issue":"1","key":"10.1016\/j.idc.2007.12.011_bib64","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/JCM.35.1.111-116.1997","article-title":"Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment","volume":"35","author":"Straubinger","year":"1997","journal-title":"J Clin Microbiol"},{"issue":"6","key":"10.1016\/j.idc.2007.12.011_bib65","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1128\/JCM.38.6.2191-2199.2000","article-title":"PCR-based quantification of Borrelia burgdorferi organisms in canine tissues over a 500-day postinfection period","volume":"38","author":"Straubinger","year":"2000","journal-title":"J Clin Microbiol"},{"issue":"10","key":"10.1016\/j.idc.2007.12.011_bib66","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1086\/345284","article-title":"Detection of attenuated, noninfectious spirochetes in Borrelia burgdorferi-infected mice after antibiotic treatment","volume":"186","author":"Bockenstedt","year":"2002","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2007.12.011_bib67","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1086\/513873","article-title":"Antitumor necrosis factor-\u03b1 treatment activates Borrelia burgdorferi spirochetes 4 weeks after ceftriaxone treatment in C3H\/He mice","volume":"195","author":"Yrjanainen","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.idc.2007.12.011_bib68","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1742-5573-3-12","article-title":"Generalizability in two clinical trials of Lyme disease","volume":"3","author":"Cameron","year":"2006","journal-title":"Epidemiol Perspect Innov"},{"issue":"2","key":"10.1016\/j.idc.2007.12.011_bib69","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1086\/518853","article-title":"Counterpoint: long-term antibiotic therapy improves persistent symptoms associated with Lyme disease","volume":"45","author":"Stricker","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2007.12.011_bib70","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1086\/512979","article-title":"Lyme disease guidelines\u2014it's time to move forward","volume":"44","author":"Donta","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2007.12.011_bib71","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1086\/516171","article-title":"Tetracycline therapy for chronic Lyme disease","volume":"25","author":"Donta","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.idc.2007.12.011_bib72","first-page":"PI136","article-title":"Macrolide therapy of chronic Lyme Disease","volume":"9","author":"Donta","year":"2003","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.idc.2007.12.011_bib73","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1478-4505-4-21","article-title":"Improving the use of research evidence in guideline development: 9. Grading evidence and recommendations","volume":"4","author":"Schunemann","year":"2006","journal-title":"Health Res Policy Syst"},{"issue":"7023","key":"10.1016\/j.idc.2007.12.011_bib74","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.312.7023.71","article-title":"Evidence-based medicine: what it is and what it isn't","volume":"312","author":"Sackett","year":"1996","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.idc.2007.12.011_bib75","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/clind\/16.4.558","article-title":"Experience at a referral center for patients with suspected Lyme disease in an area of nonendemicity: first 65 patients","volume":"16","author":"Burdge","year":"1993","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2007.12.011_bib76","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10096-007-0342-0","article-title":"Differential diagnoses of suspected Lyme borreliosis or post-Lyme disease syndrome","volume":"26","author":"Seidel","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2007.12.011_bib77","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1128\/AAC.39.3.661","article-title":"Comparison of cefuroxime axetil and doxycycline in treatment of patients with early Lyme disease associated with erythema migrans","volume":"39","author":"Luger","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.idc.2007.12.011_bib78","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s150100050069","article-title":"Comparison of azithromycin and doxycycline in the treatment of erythema migrans","volume":"28","author":"Barsic","year":"2000","journal-title":"Infection"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552007001274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552007001274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T23:33:22Z","timestamp":1588635202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552007001274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":78,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0891552007001274"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2007.12.011","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}